Hepatocellular carcinoma with extrahepatic collateral arterial supply

Cheng, Lihua; F, K; Fan, Wenlong; Yung, A W T; Li, T M; Wong, C S

doi:10.1111/j.1754-9485.2010.02134.x

Cited by 17 publications

(35 citation statements)

References 13 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[7][8][9][10][11]14] Large tumors are usually fed by multiple feeding arteries-not only hepatic arterial branches but also extrahepatic collaterals and this makes the procedure more laborious and technically difficult for achieving complete necrosis of the large tumors by TACE. [10,11] The prevalence of ECS at the initial chemoembolization session in a tumor less than 4 cm in diameter is less than 3% and this increases to 63% when the tumor is larger than 6 cm in diameter.…”

Section: Discussionmentioning

confidence: 99%

“…However, certain HCCs are prone to develop additional extrahepatic collateral arterial supply (ECS) depending on various factors like their location and size. [7][8][9][10][11] Such a situation may lead to the need of performing additional chemoembolization through the ECS in order to achieve complete local tumor response. This study aims to highlight this important aspect for effective management of HCC by TACE and to identify these difficult cases for effective tumor control.…”

Section: Introductionmentioning

confidence: 97%

See 1 more Smart Citation

Transarterial chemoembolization for hepatocellular carcinoma: Significance of extrahepatic collateral supply

et al. 2011

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 97%

Transarterial chemoembolization for hepatocellular carcinoma: Significance of extrahepatic collateral supply

et al. 2011

View full text Add to dashboard Cite

show abstract

“…This treatment modality consists of radiation, delivered to the tumor mass through the hepatic artery or via extrahepatic collateral arteries [73]. New combinations of transarterial radiotherapy with TKIs are evolving because the latter may promote angiogenesis, and sorafenib has been shown to moderate angiogenesis and resultant metastases.…”

Section: Transarterial Radiotherapymentioning

confidence: 99%

Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma

Gish¹,

Lencioni

Bisceglie

et al. 2012

Expert Review of Gastroenterology & Hepatology

View full text Add to dashboard Cite

It has long been appreciated that hepatocellular carcinoma (HCC) is a complex disease. HCC is typically preceded by liver cirrhosis, which is itself caused by various types of hepatitis of both viral and nonviral etiologies. Thus, the treatment of patients with HCC requires multiple healthcare professionals, including hepatologists, medical oncologists, surgical oncologists, transplantation surgeons, diagnostic radiologists, pathologists, nurses, nurse practitioners and interventional radiologists. These specialists should meet regularly to review patients' progress, ensure that treatments are individualized for each patient and agree on next steps. We review case presentations provided by the authors to illustrate the benefits and advantages of the multidisciplinary team matrix in the management of patients with HCC, including the effects of this treatment technique on patient outcome, survival and quality of life.

show abstract

“…However, exophytic HCC at the inferior tip of the liver (segments V and VI) may receive an EHC arterial supply from the superior mesenteric artery through its terminal branches (Fig 17). The prevalence of a parasitic supply to HCC from the superior mesenteric artery is reported to range from 0.7% to 1.5% (21,35).…”

Section: Superior Mesenteric Arterymentioning

confidence: 99%

Chemoembolization of Hepatocellular Carcinoma with Extrahepatic Collateral Blood Supply: Anatomic and Technical Considerations

et al. 2017

View full text Add to dashboard Cite

Transarterial chemoembolization (TACE) is considered a standard local-regional treatment for intermediate-stage hepatocellular carcinoma (HCC) and the most common bridging therapy. This treatment is offered to more than 70% of patients who are on the waiting list for liver transplantation in the United States. HCC typically receives its blood supply from the hepatic artery; however, it can recruit a parasitic supply from extrahepatic collateral (EHC) arteries. The development of an EHC arterial blood supply can interfere with the therapeutic efficacy of TACE and result in treatment failure and poor outcome. Cross-sectional imaging-specifically computed tomography and magnetic resonance imaging-has some limitations in depicting the presence or absence of an EHC arterial supply during the pre-TACE evaluation. Catheterization and angiography of every possible EHC artery during a routine TACE procedure would be time consuming and technically challenging and would not always be feasible. Therefore, the prediction of a potential EHC arterial supply on the basis of tumor location before, during, and after TACE is fundamental to achieving optimal therapeutic efficacy. To perform TACE through EHC arteries, special considerations are necessary to avoid potentially serious complications. The authors review the factors influencing the development of an EHC arterial blood supply to HCC and describe a systematic approach to enhance the ability to predict the presence of EHC arteries. They also describe the proper technique for TACE of each EHC artery and how to avoid potential technique-related complications. RSNA, 2017.

show abstract

Hepatocellular carcinoma with extrahepatic collateral arterial supply

Cited by 17 publications

References 13 publications

Transarterial chemoembolization for hepatocellular carcinoma: Significance of extrahepatic collateral supply

Transarterial chemoembolization for hepatocellular carcinoma: Significance of extrahepatic collateral supply

Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma

Chemoembolization of Hepatocellular Carcinoma with Extrahepatic Collateral Blood Supply: Anatomic and Technical Considerations

Contact Info

Product

Resources

About